| Name | Title | Contact Details |
|---|---|---|
Greg Bonham |
Chief Technology Officer | Profile |
Marketcetera Inc. is one of the leading providers in Software and Internet. It is based in Palo Alto, CA. To find more information about Marketcetera Inc., please visit www.marketcetera.com.
Medallia is a leading customer experience management (CEM) SaaS company. Founded in 2001, the company is trusted by some of the world`s top brands -- including Nordstrom, Mercedes-Benz, Sephora, Four Seasons, PayPal, and the Zurich Insurance Group -- to create experiences that customers love. Medallia enables companies to capture customer feedback across a multitude of channels and touchpoints (such as online, social media, mobile, and contact centers), understand it in real-time, and drive action everywhere — from the C-suite to the frontline. Medallia is a Sequoia-backed company with 98% customer retention and referencabilty. Our leading SaaS Customer Experience Management offering enables our customers to achieve measurable business value as measured by increased customer loyalty, retention, and revenue. Medallia considers itself a technology company at heart, with employees who like to create new things, and it will continue to strengthen its technology core to bring new data collection, analytics, collaboration, mobile, social, and visualization capabilities into its solution. Medallia is expanding and is looking for employees with a hunger to learn, a curiosity to understand, and the skills to develop products and deliver services that will delight our customers.
Sonitor Technologies is the only Real Time Locating System (RTLS) vendor to offer a truly tiered resolution RTLS solution that combines area, room and sub-room accuracy in one platform. A wireless, battery powered infrastructure gives the lowest Total Cost of Ownership (TCO) and at the same time offers the fastest return on investment. This, combined with unparalleled robustness and reliability, makes Sonitor the obvious choice for organizations looking for an RTLS technology partner for equipment tracking, nurse call, workflow and more. Combining best of breed technology - Ultrasound and Wi-Fi - with a range of leading partner applications ensures an RTLS platform to grow with as your company or organization’s needs for real time location data evolves.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.